Investors & News

About Vivoryon

We are focused on developing innovative small molecule-based medicines. Driven by our passion for ground-breaking science and innovation, we strive to change the lives of patients in need suffering from severe diseases. We build on our in-depth expertise in understanding post-translational modifications to develop medicines that modulate the activity and stability of proteins which are altered in disease settings.

Upcoming Events

November

.

Deutsches Eigenkapitalforum

November 22 – 24, 2021